| CVD | cardiovascular disease |
| MI | myocardial infarction |
| HF | heart failure |
| IS | ischemic stroke |
| lncRNAs | long non-coding RNAs |
| miRNAs | microRNAs |
| MALAT1 | metastasis-associated lung adenocarcinoma transcript 1 |
| STEMI | ST-elevation myocardial infarction |
| MACE | major adverse cardiovascular event |
| ceRNA | competing endogenous RNA |
| COX-2 | cyclooxygenase-2 |
| COPD | chronic obstructive pulmonary disease |
| MACCE | major adverse cardiovascular and cerebrovascular events |
| TC | total cholesterol |
| CAD | coronary artery disease |
| PBMC | peripheral blood mononuclear cell |
| PCI | percutaneous coronary intervention |
| T2DM | type 2 diabetes mellitus |
| LV | left ventricle |
| MMA | Military Medical Academy |
| LVEDD | LV end-diastolic diameter |
| LVESD | LV end-systolic diameter |
| LVEF | LV ejection fraction |
| HFrEF | heart failure with reduced ejection fraction |
| eQTLs | expression quantitative trait loci |
| LD | linkage disequilibrium |
| GWAS | genome-wide association study |
| BMI | body mass index |
| SD | standard deviation |
| HWE | Hardy–Weinberg equilibrium |
| OR | odds ratio |
| CI | confidence interval |
| HDLC | high-density lipoprotein cholesterol |
| LDLC | low-density lipoprotein cholesterol |
| TG | triglycerides |
| CKmax | peak creatine kinase level |
| CK-MBmax | peak creatine kinase–MB level |
| Tnmax | peak troponin level |
| CRP | C-reactive protein |
| UFH | unfractionated heparin |
| LMWH | low-molecular-weight heparin |
| ns | not significant |
| N/A | not applicable |
| ROS | reactive oxygen species |
| MIRI | myocardial ischemia/reperfusion injury |